<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34576228</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>18</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Dimerization of Human Angiogenin and of Variants Involved in Neurodegenerative Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10068</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms221810068</ELocationID><Abstract><AbstractText>Human Angiogenin (hANG, or ANG, 14.1 kDa) promotes vessel formation and is also called RNase 5 because it is included in the pancreatic-type ribonuclease (pt-RNase) super-family. Although low, its ribonucleolytic activity is crucial for angiogenesis in tumor tissues but also in the physiological development of the Central Nervous System (CNS) neuronal progenitors. Nevertheless, some ANG variants are involved in both neurodegenerative Parkinson disease (PD) and Amyotrophic Lateral Sclerosis (ALS). Notably, some pt-RNases acquire new biological functions upon oligomerization. Considering neurodegenerative diseases correlation with massive protein aggregation, we analyzed the aggregation propensity of ANG and of three of its pathogenic variants, namely H13A, S28N, and R121C. We found no massive aggregation, but wt-ANG, as well as S28N and R121C variants, can form an enzymatically active dimer, which is called ANG-D. By contrast, the enzymatically inactive H13A-ANG does not dimerize. Corroborated by a specific cross-linking analysis and by the behavior of H13A-ANG that in turn lacks one of the two His active site residues necessary for pt-RNases to self-associate through the three-dimensional domain swapping (3D-DS), we demonstrate that ANG actually dimerizes through 3D-DS. Then, we deduce by size exclusion chromatography (SEC) and modeling that ANG-D forms through the swapping of ANG N-termini. In light of these novelties, we can expect future investigations to unveil other ANG determinants possibly related with the onset and/or development of neurodegenerative pathologies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fasoli</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicine, and Movement Sciences, Biological Chemistry Section, University of Verona, Strada Le Grazie 8, I-37134 Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bettin</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicine, and Movement Sciences, Biological Chemistry Section, University of Verona, Strada Le Grazie 8, I-37134 Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montioli</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicine, and Movement Sciences, Biological Chemistry Section, University of Verona, Strada Le Grazie 8, I-37134 Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagagnini</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicine, and Movement Sciences, Biological Chemistry Section, University of Verona, Strada Le Grazie 8, I-37134 Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Qu&#xed;mica F&#xed;sica "Rocasolano", Consejo Superior de Investigaciones Cient&#xed;ficas, Serrano 119, E-28006 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peterle</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, University of Padua, Via Marzolo 5, I-35131 Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laurents</LastName><ForeName>Douglas V</ForeName><Initials>DV</Initials><Identifier Source="ORCID">0000-0002-4187-165X</Identifier><AffiliationInfo><Affiliation>Instituto de Qu&#xed;mica F&#xed;sica "Rocasolano", Consejo Superior de Investigaciones Cient&#xed;ficas, Serrano 119, E-28006 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gotte</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3179-7158</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicine, and Movement Sciences, Biological Chemistry Section, University of Verona, Strada Le Grazie 8, I-37134 Verona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013450">Sulfones</NameOfSubstance></Chemical><Chemical><RegistryNumber>5PFN71LP8M</RegistryNumber><NameOfSubstance UI="C009873">divinyl sulfone</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D012260">Ribonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.27.-</RegistryNumber><NameOfSubstance UI="C046366">angiogenin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.27.5</RegistryNumber><NameOfSubstance UI="D012259">Ribonuclease, Pancreatic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002845" MajorTopicYN="N">Chromatography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012259" MajorTopicYN="N">Ribonuclease, Pancreatic</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012260" MajorTopicYN="N">Ribonucleases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013450" MajorTopicYN="N">Sulfones</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3D domain swapping</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease (PD)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">human angiogenin</Keyword><Keyword MajorTopicYN="N">protein oligomerization</Keyword><Keyword MajorTopicYN="N">ribonuclease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34576228</ArticleId><ArticleId IdType="pmc">PMC8468037</ArticleId><ArticleId IdType="doi">10.3390/ijms221810068</ArticleId><ArticleId IdType="pii">ijms221810068</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Strydom D.J., Fett J.W., Lobb R.R., Alderman E.M., Bethune J.L., Riordan J.F., Vallee B.L. Amino acid sequence of human tumor derived angiogenin. Biochemistry. 1985;24:5486&#x2013;5494. doi: 10.1021/bi00341a031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00341a031</ArticleId><ArticleId IdType="pubmed">2866794</ArticleId></ArticleIdList></Reference><Reference><Citation>Fett J.W., Strydom D.J., Lobb R.R., Alderman E.M., Bethune J.L., Riordan J.F., Vallee B.L. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. 1985;24:5480&#x2013;5486. doi: 10.1021/bi00341a030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00341a030</ArticleId><ArticleId IdType="pubmed">4074709</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro R., Strydom D.J., Olson K.A., Vallee B.L. Isolation of angiogenin from normal human plasma. Biochemistry. 1987;26:5141&#x2013;5146. doi: 10.1021/bi00390a037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00390a037</ArticleId><ArticleId IdType="pubmed">3663649</ArticleId></ArticleIdList></Reference><Reference><Citation>Spong C.Y., Ghidini A., Sherer D.M., Pezzullo J.C., Ossandon M., Eglinton G.S. Angiogenin: A marker for preterm delivery in midtrimester amniotic fluid. Am. J. Obstet. Gynecol. 1997;176:415&#x2013;418. doi: 10.1016/S0002-9378(97)70508-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9378(97)70508-8</ArticleId><ArticleId IdType="pubmed">9065191</ArticleId></ArticleIdList></Reference><Reference><Citation>Strydom D.J. The angiogenins. Cell. Mol. Life Sci. 1998;54:811&#x2013;824. doi: 10.1007/s000180050210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000180050210</ArticleId><ArticleId IdType="pubmed">9760990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurachi K., Davie E.W., Strydom D.J., Riordan J.F., Vallee B.L. Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry. 1985;24:5494&#x2013;5499. doi: 10.1021/bi00341a032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00341a032</ArticleId><ArticleId IdType="pubmed">2866795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrentino S. The eight human &#x201c;canonical&#x201d; ribonucleases: Molecular diversity, catalytic properties, and special biological actions of the enzyme proteins. FEBS Lett. 2010;584:2194&#x2013;2200. doi: 10.1016/j.febslet.2010.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2010.04.018</ArticleId><ArticleId IdType="pubmed">20388512</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya K.R., Shapiro R., Allen S.C., Riordan J.F., Vallee B.L. Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc. Natl. Acad. Sci. USA. 1994;91:2915&#x2013;2919. doi: 10.1073/pnas.91.8.2915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.8.2915</ArticleId><ArticleId IdType="pmc">PMC43485</ArticleId><ArticleId IdType="pubmed">8159679</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro R., Weremowicz S., Riordan J.F., Vallee B.L. Ribonucleolytic activity of angiogenin: Essential histidine, lysine, and arginine residues. Proc. Natl. Acad. Sci. USA. 1987;84:8783&#x2013;8787. doi: 10.1073/pnas.84.24.8783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.84.24.8783</ArticleId><ArticleId IdType="pmc">PMC299634</ArticleId><ArticleId IdType="pubmed">3122207</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro R., Vallee B.L. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis. Biochemistry. 1989;28:7401&#x2013;7408. doi: 10.1021/bi00444a038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00444a038</ArticleId><ArticleId IdType="pubmed">2479414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrentino S., Libonati M. Human pancreatic-type and nonpancreatic-type ribonucleases: A direct side-by-side comparison of their catalytic properties. Arch. Biochem. Biophys. 1994;312:340&#x2013;348. doi: 10.1006/abbi.1994.1318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1994.1318</ArticleId><ArticleId IdType="pubmed">8037446</ArticleId></ArticleIdList></Reference><Reference><Citation>Wlodawer A., Svensson L.A., Sjolin L., Gilliland G.L. Structure of phosphate-free ribonuclease A refined at 1.26 A. Biochemistry. 1988;27:2705&#x2013;2717. doi: 10.1021/bi00408a010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00408a010</ArticleId><ArticleId IdType="pubmed">3401445</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper J.W., Vallee B.L. A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis. Biochemistry. 1989;28:1875&#x2013;1884. doi: 10.1021/bi00430a067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00430a067</ArticleId><ArticleId IdType="pubmed">2719939</ArticleId></ArticleIdList></Reference><Reference><Citation>Leland P.A., Staniszewski K.E., Park C., Kelemen B.R., Raines R.T. The ribonucleolytic activity of angiogenin. Biochemistry. 2002;41:1343&#x2013;1350. doi: 10.1021/bi0117899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0117899</ArticleId><ArticleId IdType="pubmed">11802736</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo N., Shapiro R., Acharya K.R., Riordan J.F., Vallee B.L. Role of glutamine-117 in the ribonucleolytic activity of human angiogenin. Proc. Natl. Acad. Sci. USA. 1994;91:2920&#x2013;2924. doi: 10.1073/pnas.91.8.2920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.8.2920</ArticleId><ArticleId IdType="pmc">PMC43486</ArticleId><ArticleId IdType="pubmed">8159680</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji T., Sun Y., Kishimoto K., Olson K.A., Liu S., Hirukawa S., Hu G.F. Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res. 2005;65:1352&#x2013;1360. doi: 10.1158/0008-5472.CAN-04-2058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-04-2058</ArticleId><ArticleId IdType="pubmed">15735021</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki S., Ivanov P., Hu G.F., Anderson P. Angiogenin cleaves tRNA and promotes stress-induced translational repression. J. Cell Biol. 2009;185:35&#x2013;42. doi: 10.1083/jcb.200811106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200811106</ArticleId><ArticleId IdType="pmc">PMC2700517</ArticleId><ArticleId IdType="pubmed">19332886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelemen B.R., Klink T.A., Behlke M.A., Eubanks S.R., Leland P.A., Raines R.T. Hypersensitive substrate for ribonucleases. Nucleic Acids Res. 1999;27:3696&#x2013;3701. doi: 10.1093/nar/27.18.3696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/27.18.3696</ArticleId><ArticleId IdType="pmc">PMC148625</ArticleId><ArticleId IdType="pubmed">10471739</ArticleId></ArticleIdList></Reference><Reference><Citation>Riordan J.F. Angiogenin. Methods Enzymol. 2001;341:263&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">11582782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.S., Lee I.S., Kang T.C., Jeong G.B., Chang S.I. Angiogenin is involved in morphological changes and angiogenesis in the ovary. Biochem. Biophys. Res. Commun. 1999;257:182&#x2013;186. doi: 10.1006/bbrc.1999.0359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1999.0359</ArticleId><ArticleId IdType="pubmed">10092530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieran D., Sebastia J., Greenway M.J., King M.A., Connaughton D., Concannon C.G., Fenner B., Hardiman O., Prehn J.H. Control of motoneuron survival by angiogenin. J. Neurosci. 2008;28:14056&#x2013;14061. doi: 10.1523/JNEUROSCI.3399-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3399-08.2008</ArticleId><ArticleId IdType="pmc">PMC6671464</ArticleId><ArticleId IdType="pubmed">19109488</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro R., Fox E.A., Riordan J.F. Role of lysines in human angiogenin: Chemical modification and site-directed mutagenesis. Biochemistry. 1989;28:1726&#x2013;1732. doi: 10.1021/bi00430a045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00430a045</ArticleId><ArticleId IdType="pubmed">2497770</ArticleId></ArticleIdList></Reference><Reference><Citation>Emara M.M., Ivanov P., Hickman T., Dawra N., Tisdale S., Kedersha N., Hu G.F., Anderson P. Angiogenin-induced tRNA-derived stress-induced RNAs promote stress-induced stress granule assembly. J. Biol. Chem. 2010;285:10959&#x2013;10968. doi: 10.1074/jbc.M109.077560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.077560</ArticleId><ArticleId IdType="pmc">PMC2856301</ArticleId><ArticleId IdType="pubmed">20129916</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzo E., Sarcinelli C., Sheng J., Fusco S., Formiggini F., Netti P., Yu W., D&#x2019;Alessio G., Hu G.F. Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival. Pt 18J. Cell Sci. 2013;126:4308&#x2013;4319. doi: 10.1242/jcs.134551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.134551</ArticleId><ArticleId IdType="pmc">PMC3772394</ArticleId><ArticleId IdType="pubmed">23843625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotte G., Menegazzi M. Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs. Front. Immunol. 2019;10:2626. doi: 10.3389/fimmu.2019.02626.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02626</ArticleId><ArticleId IdType="pmc">PMC6901985</ArticleId><ArticleId IdType="pubmed">31849926</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Riordan J.F., Hu G. Nuclear translocation of human angiogenin in cultured human umbilical artery endothelial cells is microtubule and lysosome independent. Biochem. Biophys. Res. Commun. 1997;238:305&#x2013;312. doi: 10.1006/bbrc.1997.7290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1997.7290</ArticleId><ArticleId IdType="pubmed">9299500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson R., Subramanian V. The cellular uptake of angiogenin, an angiogenic and neurotrophic factor is through multiple pathways and largely dynamin independent. PLoS ONE. 2018;13:e0193302. doi: 10.1371/journal.pone.0193302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0193302</ArticleId><ArticleId IdType="pmc">PMC5828446</ArticleId><ArticleId IdType="pubmed">29486010</ArticleId></ArticleIdList></Reference><Reference><Citation>Moroianu J., Riordan J.F. Identification of the nucleolar targeting signal of human angiogenin. Biochem. Biophys. Res. Commun. 1994;203:1765&#x2013;1772. doi: 10.1006/bbrc.1994.2391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1994.2391</ArticleId><ArticleId IdType="pubmed">7945327</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z.P., Tsuji T., Riordan J.F., Hu G.F. The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem. Biophys. Res. Commun. 2002;294:287&#x2013;292. doi: 10.1016/S0006-291X(02)00479-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-291X(02)00479-5</ArticleId><ArticleId IdType="pubmed">12051708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lixin R., Efthymiadis A., Henderson B., Jans D.A. Novel properties of the nucleolar targeting signal of human angiogenin. Biochem. Biophys. Res. Commun. 2001;284:185&#x2013;193. doi: 10.1006/bbrc.2001.4953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2001.4953</ArticleId><ArticleId IdType="pubmed">11374889</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian V., Crabtree B., Acharya K.R. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum. Mol. Genet. 2008;17:130&#x2013;149. doi: 10.1093/hmg/ddm290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm290</ArticleId><ArticleId IdType="pubmed">17916583</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagagnini A., Garavis M., Gomez-Pinto I., Fasoli S., Gotte G., Laurents D.V. NMR Characterization of Angiogenin Variants and tRNA(Ala) Products Impacting Aberrant Protein Oligomerization. Int. J. Mol. Sci. 2021;22:1439. doi: 10.3390/ijms22031439.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22031439</ArticleId><ArticleId IdType="pmc">PMC7867098</ArticleId><ArticleId IdType="pubmed">33535464</ArticleId></ArticleIdList></Reference><Reference><Citation>Crabtree B., Thiyagarajan N., Prior S.H., Wilson P., Iyer S., Ferns T., Shapiro R., Brew K., Subramanian V., Acharya K.R. Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry. 2007;46:11810&#x2013;11818. doi: 10.1021/bi701333h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi701333h</ArticleId><ArticleId IdType="pubmed">17900154</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiyagarajan N., Ferguson R., Subramanian V., Acharya K.R. Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons. Nat. Commun. 2012;3:1121. doi: 10.1038/ncomms2126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2126</ArticleId><ArticleId IdType="pmc">PMC3493651</ArticleId><ArticleId IdType="pubmed">23047679</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw W.J., Rehman S., Pham T.T., Thiyagarajan N., Lee R.L., Subramanian V., Acharya K.R. Structural insights into human angiogenin variants implicated in Parkinson&#x2019;s disease and Amyotrophic Lateral Sclerosis. Sci. Rep. 2017;7:41996. doi: 10.1038/srep41996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41996</ArticleId><ArticleId IdType="pmc">PMC5296752</ArticleId><ArticleId IdType="pubmed">28176817</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang T.T., Raines R.T. Molecular basis for the autonomous promotion of cell proliferation by angiogenin. Nucleic Acids Res. 2017;45:818&#x2013;831. doi: 10.1093/nar/gkw1192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1192</ArticleId><ArticleId IdType="pmc">PMC5314776</ArticleId><ArticleId IdType="pubmed">27915233</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., et al. ANG mutations segregate with familial and &#x2019;sporadic&#x2019; amyotrophic lateral sclerosis. Nat. Genet. 2006;38:411&#x2013;413. doi: 10.1038/ng1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1742</ArticleId><ArticleId IdType="pubmed">16501576</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Schelhaas H.J., van Vught P.W., Ticozzi N., Andersen P.M., Groen E.J., Schulte C., Blauw H.M., Koppers M., Diekstra F.P., et al. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann. Neurol. 2011;70:964&#x2013;973. doi: 10.1002/ana.22611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22611</ArticleId><ArticleId IdType="pmc">PMC5560057</ArticleId><ArticleId IdType="pubmed">22190368</ArticleId></ArticleIdList></Reference><Reference><Citation>Libonati M., Gotte G. Oligomerization of bovine ribonuclease A: Structural and functional features of its multimers. Biochem. J. 2004;380:311&#x2013;327. doi: 10.1042/bj20031922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj20031922</ArticleId><ArticleId IdType="pmc">PMC1224197</ArticleId><ArticleId IdType="pubmed">15104538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotte G., Mahmoud Helmy A., Ercole C., Spadaccini R., Laurents D.V., Donadelli M., Picone D. Double domain swapping in bovine seminal RNase: Formation of distinct N- and C-swapped tetramers and multimers with increasing biological activities. PLoS ONE. 2012;7:e46804. doi: 10.1371/journal.pone.0046804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046804</ArticleId><ArticleId IdType="pmc">PMC3469567</ArticleId><ArticleId IdType="pubmed">23071641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagagnini A., Pica A., Fasoli S., Montioli R., Donadelli M., Cordani M., Butturini E., Acquasaliente L., Picone D., Gotte G. Onconase dimerization through 3D domain swapping: Structural investigations and increase in the apoptotic effect in cancer cells. Biochem. J. 2017;474:3767&#x2013;3781. doi: 10.1042/BCJ20170541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20170541</ArticleId><ArticleId IdType="pubmed">28963346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M.J., Schlunegger M.P., Eisenberg D. 3D domain swapping: A mechanism for oligomer assembly. Protein Sci. 1995;4:2455&#x2013;2468. doi: 10.1002/pro.5560041202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.5560041202</ArticleId><ArticleId IdType="pmc">PMC2143041</ArticleId><ArticleId IdType="pubmed">8580836</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Yu W., Kishikawa H., Folkerth R.D., Iafrate A.J., Shen Y., Xin W., Sims K., Hu G.F. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann. Neurol. 2007;62:609&#x2013;617. doi: 10.1002/ana.21221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21221</ArticleId><ArticleId IdType="pmc">PMC2776820</ArticleId><ArticleId IdType="pubmed">17886298</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccoli R., Tamburrini M., Piccialli G., Di Donato A., Parente A., D&#x2019;Alessio G. The dual-mode quaternary structure of seminal RNase. Proc. Natl. Acad. Sci. USA. 1992;89:1870&#x2013;1874. doi: 10.1073/pnas.89.5.1870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.5.1870</ArticleId><ArticleId IdType="pmc">PMC48555</ArticleId><ArticleId IdType="pubmed">1542685</ArticleId></ArticleIdList></Reference><Reference><Citation>Butturini E., Gotte G., Dell&#x2019;Orco D., Chiavegato G., Marino V., Canetti D., Cozzolino F., Monti M., Pucci P., Mariotto S. Intermolecular disulfide bond influences unphosphorylated STAT3 dimerization and function. Biochem. J. 2016;473:3205&#x2013;3219. doi: 10.1042/BCJ20160294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160294</ArticleId><ArticleId IdType="pubmed">27486258</ArticleId></ArticleIdList></Reference><Reference><Citation>Crestfield A.M., Stein W.H., Moore S. On the aggregation of bovine pancreatic ribonuclease. Arch. Biochem. Biophys. 1962;((Suppl. 1)):217&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">14023810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Alonso J.P., Bruix M., Font J., Ribo M., Vilanova M., Rico M., Gotte G., Libonati M., Gonzalez C., Laurents D.V. Formation, structure, and dissociation of the ribonuclease S three-dimensional domain-swapped dimer. J. Biol. Chem. 2006;281:9400&#x2013;9406. doi: 10.1074/jbc.M510491200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M510491200</ArticleId><ArticleId IdType="pubmed">16415350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciglic M.I., Jackson P.J., Raillard S.A., Haugg M., Jermann T.M., Opitz J.G., Trabesinger-Ruf N., Benner S.A. Origin of dimeric structure in the ribonuclease superfamily. Biochemistry. 1998;37:4008&#x2013;4022. doi: 10.1021/bi972203e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi972203e</ArticleId><ArticleId IdType="pubmed">9521722</ArticleId></ArticleIdList></Reference><Reference><Citation>Nenci A., Gotte G., Bertoldi M., Libonati M. Structural properties of trimers and tetramers of ribonuclease A. Protein Sci. 2001;10:2017&#x2013;2027. doi: 10.1110/ps.14101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.14101</ArticleId><ArticleId IdType="pmc">PMC2374226</ArticleId><ArticleId IdType="pubmed">11567093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotte G., Laurents D.V., Libonati M. Three-dimensional domain-swapped oligomers of ribonuclease A: Identification of a fifth tetramer, pentamers and hexamers, and detection of trace heptameric, octameric and nonameric species. Biochim. Biophys. Acta. 2006;1764:44&#x2013;54. doi: 10.1016/j.bbapap.2005.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2005.10.011</ArticleId><ArticleId IdType="pubmed">16310422</ArticleId></ArticleIdList></Reference><Reference><Citation>Montioli R., Campagnari R., Fasoli S., Fagagnini A., Caloiu A., Smania M., Menegazzi M., Gotte G. RNase A Domain-Swapped Dimers Produced Through Different Methods: Structure-Catalytic Properties and Antitumor Activity. Life (Basel) 2021;11:168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7926746</ArticleId><ArticleId IdType="pubmed">33669993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Eisenberg D. 3D domain swapping: As domains continue to swap. Protein Sci. 2002;11:1285&#x2013;1299. doi: 10.1110/ps.0201402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.0201402</ArticleId><ArticleId IdType="pmc">PMC2373619</ArticleId><ArticleId IdType="pubmed">12021428</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotte G., Bertoldi M., Libonati M. Structural versatility of bovine ribonuclease A. Distinct conformers of trimeric and tetrameric aggregates of the enzyme. Eur. J. Biochem. 1999;265:680&#x2013;687. doi: 10.1046/j.1432-1327.1999.00761.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1327.1999.00761.x</ArticleId><ArticleId IdType="pubmed">10504400</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C., Kelemen B.R., Klink T.A., Sweeney R.Y., Behlke M.A., Eubanks S.R., Raines R.T. Fast, facile, hypersensitive assays for ribonucleolytic activity. Methods Enzymol. 2001;341:81&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">11582813</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Gotte G., Libonati M., Eisenberg D. Structures of the two 3D domain-swapped RNase A trimers. Protein Sci. 2002;11:371&#x2013;380. doi: 10.1110/ps.36602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.36602</ArticleId><ArticleId IdType="pmc">PMC2373430</ArticleId><ArticleId IdType="pubmed">11790847</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Hart P.J., Schlunegger M.P., Eisenberg D. The crystal structure of a 3D domain-swapped dimer of RNase A at a 2.1-A resolution. Proc. Natl. Acad. Sci. USA. 1998;95:3437&#x2013;3442. doi: 10.1073/pnas.95.7.3437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.7.3437</ArticleId><ArticleId IdType="pmc">PMC19854</ArticleId><ArticleId IdType="pubmed">9520384</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Gotte G., Libonati M., Eisenberg D. A domain-swapped RNase A dimer with implications for amyloid formation. Nat. Struct. Biol. 2001;8:211&#x2013;214. doi: 10.1038/84941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/84941</ArticleId><ArticleId IdType="pubmed">11224563</ArticleId></ArticleIdList></Reference><Reference><Citation>Vottariello F., Giacomelli E., Frasson R., Pozzi N., De Filippis V., Gotte G. RNase A oligomerization through 3D domain swapping is favoured by a residue located far from the swapping domains. Biochimie. 2011;93:1846&#x2013;1857. doi: 10.1016/j.biochi.2011.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2011.07.005</ArticleId><ArticleId IdType="pubmed">21771635</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlino A., Picone D., Ercole C., Balsamo A., Sica F. Chain termini cross-talk in the swapping process of bovine pancreatic ribonuclease. Biochimie. 2012;94:1108&#x2013;1118. doi: 10.1016/j.biochi.2012.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2012.01.010</ArticleId><ArticleId IdType="pubmed">22273774</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlino A., Ercole C., Picone D., Pizzo E., Mazzarella L., Sica F. The buried diversity of bovine seminal ribonuclease: Shape and cytotoxicity of the swapped non-covalent form of the enzyme. J. Mol. Biol. 2008;376:427&#x2013;437. doi: 10.1016/j.jmb.2007.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.11.008</ArticleId><ArticleId IdType="pubmed">18164315</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotte G., Donadelli M., Laurents D.V., Vottariello F., Morbio M., Libonati M. Increase of RNase a N-terminus polarity or C-terminus apolarity changes the two domains&#x2019; propensity to swap and form the two dimeric conformers of the protein. Biochemistry. 2006;45:10795&#x2013;10806. doi: 10.1021/bi060933t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi060933t</ArticleId><ArticleId IdType="pubmed">16953565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ercole C., Colamarino R.A., Pizzo E., Fogolari F., Spadaccini R., Picone D. Comparison of the structural and functional properties of RNase A and BS-RNase: A stepwise mutagenesis approach. Biopolymers. 2009;91:1009&#x2013;1017. doi: 10.1002/bip.21176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.21176</ArticleId><ArticleId IdType="pubmed">19263489</ArticleId></ArticleIdList></Reference><Reference><Citation>Notomista E., Cafaro V., Fusiello R., Bracale A., D&#x2019;Alessio G., Di Donato A. Effective expression and purification of recombinant onconase, an antitumor protein. FEBS Lett. 1999;463:211&#x2013;215. doi: 10.1016/S0014-5793(99)01623-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(99)01623-3</ArticleId><ArticleId IdType="pubmed">10606723</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M.J., Sawaya M.R., Eisenberg D. Deposition diseases and 3D domain swapping. Structure. 2006;14:811&#x2013;824. doi: 10.1016/j.str.2006.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2006.03.011</ArticleId><ArticleId IdType="pubmed">16698543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotte G., Vottariello F., Libonati M. Thermal aggregation of ribonuclease A. A contribution to the understanding of the role of 3D domain swapping in protein aggregation. J. Biol. Chem. 2003;278:10763&#x2013;10769. doi: 10.1074/jbc.M213146200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M213146200</ArticleId><ArticleId IdType="pubmed">12533538</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro R., Vallee B.L. Interaction of human placental ribonuclease with placental ribonuclease inhibitor. Biochemistry. 1991;30:2246&#x2013;2255. doi: 10.1021/bi00222a030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00222a030</ArticleId><ArticleId IdType="pubmed">1998683</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitmore L., Wallace B.A. Protein secondary structure analyses from circular dichroism spectroscopy: Methods and reference databases. Biopolymers. 2008;89:392&#x2013;400. doi: 10.1002/bip.20853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.20853</ArticleId><ArticleId IdType="pubmed">17896349</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotte G., Libonati M. Two different forms of aggregated dimers of ribonuclease A. Biochim. Biophys. Acta. 1998;1386:106&#x2013;112. doi: 10.1016/S0167-4838(98)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4838(98)00087-9</ArticleId><ArticleId IdType="pubmed">9675255</ArticleId></ArticleIdList></Reference><Reference><Citation>Raines R.T. Ribonuclease A. Chem. Rev. 1998;98:1045&#x2013;1066. doi: 10.1021/cr960427h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr960427h</ArticleId><ArticleId IdType="pubmed">11848924</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber T., Mavratzas A., Kiesgen S., Haase S., Botticher B., Exner E., Mier W., Grosse-Hovest L., Jager D., Arndt M.A., et al. A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells. J. Immunol. Res. 2015;2015:561814. doi: 10.1155/2015/561814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/561814</ArticleId><ArticleId IdType="pmc">PMC4641194</ArticleId><ArticleId IdType="pubmed">26605343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobe B., Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature. 1993;366:751&#x2013;756. doi: 10.1038/366751a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/366751a0</ArticleId><ArticleId IdType="pubmed">8264799</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkoski T.J., Raines R.T. Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity. Curr. Pharm. Biotechnol. 2008;9:185&#x2013;199. doi: 10.2174/138920108784567344.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920108784567344</ArticleId><ArticleId IdType="pmc">PMC2818677</ArticleId><ArticleId IdType="pubmed">18673284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng J., Xu Z. Three decades of research on angiogenin: A review and perspective. Acta. Biochim. Biophys. Sin (Shanghai) 2016;48:399&#x2013;410. doi: 10.1093/abbs/gmv131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmv131</ArticleId><ArticleId IdType="pmc">PMC4888354</ArticleId><ArticleId IdType="pubmed">26705141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>